Ventricular intracranial (communicating) shunt is a medical device used to treat hydrocephalus, a condition characterized by the accumulation of excess cerebrospinal fluid in the brain. While the shunt is effective in managing hydrocephalus, it can also lead to infection and inflammatory reactions, which can be life-threatening if left untreated.
The risk of infection and inflammation increases with the duration of the shunt in place, and it is more common in children than in adults. The most common microorganisms causing infection are Staphylococcus epidermidis and Staphylococcus aureus, although other bacteria and fungi can also cause infection.
Symptoms of infection and inflammation due to ventricular intracranial shunt include fever, headache, nausea, vomiting, lethargy, irritability, and changes in behavior. In severe cases, patients may experience seizures, coma, or death.
Prevention is the key to avoiding infection and inflammatory reactions due to ventricular intracranial shunts. The following measures can be taken to reduce the risk of infection:
If infection or inflammation occurs, the treatment depends on the severity of the condition. Mild cases may be treated with antibiotics, while more severe cases may require shunt removal and intravenous antibiotics. In some cases, surgery may be necessary to remove infected tissue or repair damage caused by the shunt.
In conclusion, ventricular intracranial (communicating) shunts are effective in treating hydrocephalus but can also lead to infection and inflammatory reactions. Prevention is the key to avoiding these complications, and early intervention is crucial to ensure a positive outcome. Patients and caregivers should be vigilant in monitoring for signs of infection and inflammation and seek medical attention promptly if they occur.